Induction of IL6/STAT3-dependent TRAIL expression that contributes to the therapeutic efficacy of osimertinib in EGFR mutant NSCLC cells

作者：You-Take Oh, Zhen Chen, Dongsheng Wang, Suresh S. Ramalingam, Shi‐Yong Sun · 发表于：Oncogene · 年份：2025 · DOI：10.1038/s41388-025-03381-5 · 被引用次数：6 · 研究领域：Cell death mechanisms and regulation、Lung Cancer Treatments and Mutations、Cytokine Signaling Pathways and Interactions